DiaMedica Therapeutics Inc. (DMAC) stock
DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$8.59+0.21 (+2.51%)
Close on Nov 18, 2026Market cap $463.22MP/E –Yield –
DiaMedica Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
DiaMedica Therapeutics's revenue for the twelve months ending Dec 31, 2018 was $500.00K. For fiscal 2018 it was $500.00K.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $500.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2018 | Dec 31, 2018 | $0 | – |
| Q3 FY2018 | Sep 30, 2018 | $500.00K | – |
See a number that looks wrong?